Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics: Guidance for Industry - FDA Guidance Document

Clinical Pharmacology Considerations for the Development of Oligonucleotide Therapeutics: Guidance for Industry - FDA Guidance Document | Global Key Solutions